-
Mashup Score: 9Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review - 6 month(s) ago
Abstract Despite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning fie…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Can Artificial Intelligence Enhance Syncope Management?: A JACC: Advances Multidisciplinary Collaborative Statement - 7 month(s) ago
Abstract Syncope, a form of transient loss of consciousness, remains a complex medical condition for which adverse cardiovascular outcomes, including death, are of major concern but rarely occur. C…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
ACC/ESC joint session on #AI Revolution in #Cardiology at #ESCCongress is underway, co-chaired by #ACCPresident @HadleyWilsonMD. Learn more in our related #JACCBTS/#JACCAdvances 📄: AI & Syncope Mgmt: https://t.co/qeikI0SxB2 AI in #TranslationalResearch: https://t.co/x8GE63tlhs https://t.co/n1SJyTvT2C
-
-
Mashup Score: 4Liquid biopsies one step closer to entering the clinic to help guide - 8 month(s) ago
A simple blood test can identify specific genetic mutations in patients’ breast tumours to help guide their treatment and assess how likely patients are to relapse, a study shows.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 11Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions - 8 month(s) ago
Summary The win ratio was introduced into cardiovascular trials as a potentially better way of analyzing composite endpoints to account for the hierarchy of clinical significance of their component…
Source: www.jacc.orgCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 2MAP 2023: Abstracts - 9 month(s) ago
The abstract submission system is now open!
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#MAP2023 📢 @FAndreMD on why you should submit your abstract to the leading global meeting in #precisiononcology. Meet the best scientists in the world in #translationalresearch & find outstanding networking opportunities. https://t.co/Qbu1cf0xTB @GroupeUnicancer @CRUKresearch https://t.co/lLyibNKXiu
-
-
Mashup Score: 0On the horizon of translational research - 9 month(s) ago
Tumour agnostic targeted agents and ‘smarter’ dynamic designs are major areas of interest leading to more patient-centric approaches in cancer care
Source: Daily ReporterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Home - 12 month(s) ago
iwCAR-T is an annual workshop/think-tank bringing together leading international clinical and translational research minds in CAR-T and cell therapies for both solid and blood cancers in a face-to-face forum.
Source: iwcar-t.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Home - 1 year(s) ago
iwCAR-T is an annual workshop/think-tank bringing together leading international clinical and translational research minds in CAR-T and cell therapies for both solid and blood cancers in a face-to-face forum.
Source: iwcar-t.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Home - 1 year(s) ago
iwCAR-T is an annual workshop/think-tank bringing together leading international clinical and translational research minds in CAR-T and cell therapies for both solid and blood cancers in a face-to-face forum.
Source: iwcar-t.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Home - 1 year(s) ago
iwCAR-T is an annual workshop/think-tank bringing together leading international clinical and translational research minds in CAR-T and cell therapies for both solid and blood cancers in a face-to-face forum.
Source: iwcar-t.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
#GCOS2023 #JACCCardioOnc SimPub: Catch up on the latest #TranslationalResearch in improving #cardiovascular health & reducing #cardiotoxicity following cancer therapies in this state-of-the-art review: https://t.co/zmtpM6ijIT #CardioOnc #CardioTwitter https://t.co/BsJL3VY0Qu